SARS-CoV-2 immunity and functional recovery of COVID-19 patients 1-year after infection
SARS-CoV-2 감염 1년 후 COVID-19 환자의 면역 및 기능 회복
Clinical Trial
Published on
Journal: Signal Transduction and Targeted Therapy [Category] MERS, SARS, 변종, 임상, 진단, 치료기술, 치료제,
Journal: Signal Transduction and Targeted Therapy [Category] MERS, SARS, 변종, 임상, 진단, 치료기술, 치료제,
[키워드] 95% CI
Adaptive immunity
analyzed
Anti-RBD IgG
anti-receptor-binding domain
antibody
B.1.1.7
B.1.351
B.1.351 variant
B.1.351 variants
chemiluminescence
chemiluminescence immunoassay
Chest CT
China
consequence
COVID-19
COVID-19 patient
COVID-19-related symptoms
detectable
Diagnosis
discharge
estimate
functional
General population
highlight
immune
immune protection
Immunity
implication
Infection
Infectious diseases
life
long-lasting
neutralization
non-severe patient
Outcomes research
participant
Patient
Predictive
preventive measure
preventive measures
prospective cohort
Pulmonary function
Quality of life
RBD
Re-infection
recovered COVID-19 patient
reduced
remained
reported
risk
SARS-CoV-2 immunity
SARS-COV-2 infection
Seroprevalence
Severe patient
severe patients
significantly
Survivors
symptomatic
Total
variant
WT SARS-CoV-2
[DOI] 10.1038/s41392-021-00777-z PMC 바로가기 [Article Type] Clinical Trial
[DOI] 10.1038/s41392-021-00777-z PMC 바로가기 [Article Type] Clinical Trial